Sort by

Send to

Choose Destination

Links from PubMed

Items: 9


A fully synthetic and biochemically validated phosphatidyl inositol-3-phosphate hapten via asymmetric synthesis and native chemical ligation.

Chandler BD, Burkhardt AL, Foley K, Cullis C, Driscoll D, Roy D'Amore N, Miller SJ.

J Am Chem Soc. 2014 Jan 8;136(1):412-8. doi: 10.1021/ja410750a.


Development of orally active inhibitors of protein and cellular fucosylation.

Okeley NM, Alley SC, Anderson ME, Boursalian TE, Burke PJ, Emmerton KM, Jeffrey SC, Klussman K, Law CL, Sussman D, Toki BE, Westendorf L, Zeng W, Zhang X, Benjamin DR, Senter PD.

Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5404-9. doi: 10.1073/pnas.1222263110.


A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity.

Ng PP, Jia M, Patel KG, Brody JD, Swartz JR, Levy S, Levy R.

Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14526-31. doi: 10.1073/pnas.1211018109.


Immunotherapy for B-cell lymphoma: current status and prospective advances.

Hollander N.

Front Immunol. 2012 Jan 24;3:3. doi: 10.3389/fimmu.2012.00003.


Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees.

Varghese B, Widman A, Do J, Taidi B, Czerwinski DK, Timmerman J, Levy S, Levy R.

Blood. 2009 Nov 12;114(20):4477-85. doi: 10.1182/blood-2009-05-223263.


Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.

Olafsen T, Betting D, Kenanova VE, Salazar FB, Clarke P, Said J, Raubitschek AA, Timmerman JM, Wu AM.

J Nucl Med. 2009 Sep;50(9):1500-8. doi: 10.2967/jnumed.108.060426.


Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.

Timmerman JM, Vose JM, Czerwinski DK, Weng WK, Ingolia D, Mayo M, Denney DW, Levy R.

Leuk Lymphoma. 2009 Jan;50(1):37-46. doi: 10.1080/10428190802563355.


Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines.

Kafi K, Betting DJ, Yamada RE, Bacica M, Steward KK, Timmerman JM.

Mol Immunol. 2009 Jan;46(3):448-56. doi: 10.1016/j.molimm.2008.10.020.


Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells.

Betting DJ, Mu XY, Kafi K, McDonnel D, Rosas F, Gold DP, Timmerman JM.

Vaccine. 2009 Jan 7;27(2):250-9. doi: 10.1016/j.vaccine.2008.10.055.

Items per page

Supplemental Content

Support Center